NCT00081809View on ClinicalTrials.gov

A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Lymphoma, FollicularLymphoma, Small Lymphocytic

Interventions

DRUG

autologous human tumor-derived HSPPC-96

Trial Locations (1)

77030

M.D. Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Agenus Inc.

INDUSTRY